Forum

Notifications

Clear all

NAD+ Questions

GENERAL DISCUSSION

Last Post by mixtri 2 years ago

3 Posts

3 Users

0 Reactions

465 Views

RSS

Posts: 1

kjeremygreene

Topic starter

Apr 28, 2024 6:56 pm

(@kjeremygreene)

New Member

Joined: 2 years ago

I see companies selling NAD+ in a 100mg amount in powder. The question is that it seem really hard to find out what protocol would be used. Such as mixing amount, dosing, and freq. Any suggestions on this?

2 Replies

Share:

4 Forums
204 Topics
1,640 Posts
0 Online
8,008 Members

Forum Icons: Forum contains no unread posts Forum contains unread posts

Topic Icons: Not Replied Replied Active Hot Sticky Unapproved Solved Private Closed

Powered by wpForo Powered by wpForo version 2.4.13

Your IP Address: 216.73.217.48

HOW TO RECONSTITUTE PEPTIDES

INFORMATION:

Semaglutide and Weight Loss: Insights from Animal Studies (Rodents, 2020)
Introduction Obesity remains a global health concern, leading researchers to explore innovative approaches for weight management. Among these approaches, the study titled “Semaglutide… Read more: Semaglutide and Weight Loss: Insights from Animal Studies (Rodents, 2020)
Selank Study: Pioneering a Pathway to Stress Resilience and Cognitive Enhancement
Introduction In an ever-demanding world, stress and cognitive challenges have become pervasive issues. The study titled “Selank Ameliorates the Depression-like Behaviors and Cognitive… Read more: Selank Study: Pioneering a Pathway to Stress Resilience and Cognitive Enhancement
Melanotan II Study: A Glimpse of Hope in Reversing Autistic Traits
Introduction The pursuit of innovative treatments for Autism Spectrum Disorder (ASD) continues to be a priority in medical research. In this endeavor, the… Read more: Melanotan II Study: A Glimpse of Hope in Reversing Autistic Traits
BPC 157 study into Glaucoma and Other Ocular Conditions
Introduction In the realm of ocular health, researchers have long sought innovative therapies to address conditions such as glaucoma and other ocular disorders.… Read more: BPC 157 study into Glaucoma and Other Ocular Conditions
Unveiling the Potential of Thymosin Beta-4 (TB-500) in Alzheimer’s Disease Therapy
Introduction In the landscape of medical research, the pursuit of innovative treatments for neurodegenerative diseases remains a challenge that drives scientific exploration. Among… Read more: Unveiling the Potential of Thymosin Beta-4 (TB-500) in Alzheimer’s Disease Therapy

Forum

NAD+ Questions

Recent Forum Posts

Forum Categories

INFORMATION: